THE POPLITEAL LYMPH-NODE ASSAY IN 1996

Citation
J. Descotes et al., THE POPLITEAL LYMPH-NODE ASSAY IN 1996, Toxicology, 119(1), 1997, pp. 45-49
Citations number
21
Categorie Soggetti
Toxicology,"Pharmacology & Pharmacy
Journal title
ISSN journal
0300483X
Volume
119
Issue
1
Year of publication
1997
Pages
45 - 49
Database
ISI
SICI code
0300-483X(1997)119:1<45:TPLAI1>2.0.ZU;2-1
Abstract
The popliteal lymph node (PLN) assay is based on the assumption that a mechanism similar to a graft-versus-host (GvH) reaction is involved i n 'GvH-like' drug-induced side-effects, including generalized lymphade nopathy, serum sickness-like disease, scleroderma-like reaction and th e lupus syndrome. An increased PLN weight 7-10 days after injection of the test article into the footpad is generally held as a positive res ponse. Most, if not all compounds reported to induce pseudo-GvH side-e ffects in man (namely positive model compounds) have been shown to ind uce positive PLN responses in mice and/or rats. Reproducible results h ave been obtained in several laboratories, in some instances blindly. However, positive responses have also been obtained with the negative model compounds acetone and imipramine. Flow cytometry analysis and co nventional histology failed to help differentiate between a true GvH r esponse and a primary irritative effect. In order to confirm the poten tial value of the PLN assay to predict the risk for drug-induced GvH-l ike reactions, mechanistic studies are urgently needed. (C) 1997 Elsev ier Science Ireland Ltd.